In ads run in several news brands this week, the campaign urges the government to roll out an antiviral drug that could allow half a million immunocompromised people to stop shielding from Covid
Evusheld, available in 32 other countries but not cleared for use in the UK, would mean immunocompromised people would be able to lead more normal lives again without the fear of Covid becoming a serious danger to their health.
The Media Leader reported several news brands donated space for the campaign in their Monday print editions, with the ads created pro bono by independent agency The&Partnership and planned free of charge by sister agency mSix&Partners.
Lesley-Ann Simons, data team manager at Mediatel and affected by the lack of treatment available, told Mediatel’s news website The Media Leader: “It’s been tough, mentally and physically, especially knowing that other countries have Evusheld. It does feel like we’ve been left behind to rot which has definitely had an effect on mental health.”
